| __timestamp | Alnylam Pharmaceuticals, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 52602000 |
| Thursday, January 1, 2015 | 41097000 | 105812000 |
| Friday, January 1, 2016 | 47159000 | 113485000 |
| Sunday, January 1, 2017 | 76545000 | 285461000 |
| Monday, January 1, 2018 | 73106000 | 141726000 |
| Tuesday, January 1, 2019 | 194688000 | 150446000 |
| Wednesday, January 1, 2020 | 414801000 | 224227000 |
| Friday, January 1, 2021 | 704143000 | 361897000 |
| Saturday, January 1, 2022 | 868601000 | 520812000 |
| Sunday, January 1, 2023 | 1517886000 | 636892000 |
| Monday, January 1, 2024 | 1924873000 | 855907000 |
Cracking the code
In the dynamic world of biotechnology, Alnylam Pharmaceuticals and Halozyme Therapeutics have carved distinct paths over the past decade. From 2014 to 2023, Alnylam's gross profit surged by an astounding 2,900%, reflecting its strategic advancements and market penetration. In contrast, Halozyme's gross profit grew by approximately 1,100%, showcasing its steady yet impressive growth trajectory.
Alnylam's gross profit leap from 2014's modest $51 million to a remarkable $1.5 billion in 2023 underscores its innovative prowess and market adaptability. Meanwhile, Halozyme's journey from $53 million to $637 million highlights its consistent performance and resilience in a competitive landscape.
This analysis not only highlights the financial growth of these companies but also reflects broader trends in the biotech industry, where innovation and strategic execution are key to success.
Gross Profit Trends Compared: Novartis AG vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Pfizer Inc. or Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Sanofi vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Halozyme Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. vs Halozyme Therapeutics, Inc.: Examining Key Revenue Metrics
Gross Profit Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Ascendis Pharma A/S
Alnylam Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Halozyme Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Jazz Pharmaceuticals plc and Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Halozyme Therapeutics, Inc. and Pharming Group N.V.
Gross Profit Trends Compared: Halozyme Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.